Caroline Dorsa

Track

Insider profile

Currently holds positions in Biogen Inc, Intellia Therapeutics Inc, Illumina Inc, Goldman Sachs MLP and Energy Renaissance Fund and Goldman Sachs MLP Income Opportunities Fund

Performance

Overall performance
2.6
Performance over holding periods
2.6
30 days 90 days 120 days
Average return 3% 8.2% 15.1%
Success rate 49% 68% 82%
Transactions
5 20% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance

Positions

Position Company Period
Independent Director Biogen Inc Jan. 3, 2010 -
Independent Director Intellia Therapeutics Inc Dec. 1, 2015 -
Independent Director Illumina Inc Jan. 26, 2017 -
Independent Trustee Goldman Sachs MLP and Energy Renaissance Fund Jan. 1, 2016 -
Independent Trustee Goldman Sachs MLP Income Opportunities Fund Sept. 15, 2016 -
Chief Financial Officer, Executive Vice President Public Service Enterprise Group Inc April 9, 2009 - Oct. 8, 2015
Caroline Dorsa's trades of Biogen Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2025-05-05 2025-05-02
US Biogen Inc (BIIB)
B Purchase
59,125 +40.7%
111.96
US$451,061 		59,125 +40.7% 111.96 US$451,061
2021-06-14 2021-06-10
US Illumina Inc (ILMN)
PlS Planned sale
92,421 +26.1%
208.44
US$3,680,275 		92,421 +26.1% 208.44 US$3,680,275
2021-04-06 2021-04-05
PlS Planned sale
73,519 +40.5%
340.72
US$3,002,469 		73,519 +40.5% 340.72 US$3,002,469
2021-04-06 2021-04-05
PlS Planned sale
4,686 -43.0%
82.35
US$385,892 		4,686 -43.0% 82.35 US$385,892
2021-04-06 2021-04-05
PlS Planned sale
2,014 -15.6%
81.49
US$164,121 		2,014 -15.6% 81.49 US$164,121
2006-02-08 2006-02-07
S Sale
63,299 -80.2%
34.05
US$2,155,356 		63,299 -80.2% 34.05 US$2,155,356
2004-10-27 2004-10-26
S Sale
25,000 -61.5%
30.35
US$758,750 		25,000 -61.5% 30.35 US$758,750
2004-10-27 2004-10-26
S Sale
25,000 -38.1%
30.38
US$759,500 		25,000 -38.1% 30.38 US$759,500
2004-10-27 2004-10-26
S Sale
13,299 -16.8%
30.39
US$404,157 		13,299 -16.8% 30.39 US$404,157